New Enzyme ApPT Could Revolutionize Cancer and Anti-Inflammatory Drug Development

Scientists have uncovered a new enzyme that could transform drug development for cancer, inflammation, and viral infections. The breakthrough involves ApPT, a bacterial enzyme capable of precisely modifying complex plant-derived compounds called pentacyclic triterpenoids (PTs). These molecules, known for their therapeutic potential, have long been difficult to alter efficiently—until now. A research team led by Zhang, Chen, Wang, and collaborators identified ApPT through a bioinformatics-driven strategy. This approach combined computational predictions, structural analysis, and biocatalytic testing. The enzyme stands out for its ability to control oxidation reactions at specific carbon-hydrogen (C-H) bonds in PTs with exceptional precision.

ApPT can selectively hydroxylate aliphatic sites on PTs, targeting positions previously considered inaccessible. This level of control allows scientists to fine-tune the molecular structure of compounds like betulinic acid, ursolic acid, and oleanolic acid—all of which have shown promise in treating melanoma, prostate cancer, arthritis, and HIV. By enabling such targeted modifications, ApPT opens the door to creating derivatives with improved potency, fewer side effects, and better absorption in the body. The new method merges biocatalysis with traditional chemical synthesis, offering a more sustainable and scalable way to produce PT-based drugs. Unlike conventional techniques, which often require harsh conditions and yield unwanted by-products, ApPT operates under mild settings with high efficiency. This aligns with green chemistry principles, reducing waste and cutting costs for clinical trials. Beyond its immediate applications, the study demonstrates a broader model for enzyme discovery. The bioinformatics-guided framework used to find ApPT can now be applied to other natural product classes, accelerating the search for new biocatalysts.

The discovery of ApPT provides a powerful tool for drug developers working with complex plant compounds. Its precision in modifying PTs could lead to more effective treatments for cancer, inflammation, and viral diseases. With a scalable and eco-friendly approach, this advancement also sets a precedent for future enzyme-based innovations in medicine.